Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program
Blue Matter Launches People and Organization Practice to Help Biopharma Navigate Structural Shift [Yahoo! Finance]
Retinal Surgery Device Company Benchmark Report 2025: Key Players Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033 [Yahoo! Finance]
Should Bausch Health's Profit Return and 2026 Outlook Shift the Investment Case for BHC? [Yahoo! Finance]
Bausch Health Cos (BHC) had its price target lowered by Barclays PLC from $8.00 to $7.00. They now have an "equal weight" rating on the stock.